HUP0302767A2 - Hisztamin receptor antagonista hatóanyagok - Google Patents

Hisztamin receptor antagonista hatóanyagok Download PDF

Info

Publication number: HUP0302767A2
Authority: HU; Hungary
Prior art keywords: histamine; receptor; active ingredient; antagonist; combination
Prior art date: 2001-01-17

Application number

HU0302767A

Other languages

English (en)

Hungarian (hu)

Inventor

Stephen Jenkinson

Mark Anthony O'reilly

Michael Andrew Trevethick

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-17

Filing date

2002-01-10

Publication date

2003-11-28

2002-01-10 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2003-11-28 Publication of HUP0302767A2 publication Critical patent/HUP0302767A2/hu

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HU0302767A 2001-01-17 2002-01-10 Hisztamin receptor antagonista hatóanyagok HUP0302767A2 (hu)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0101223.6A GB0101223D0 (en)	2001-01-17	2001-01-17	Histamine receptor antagonists
PCT/IB2002/000042 WO2002056871A2 (en)	2001-01-17	2002-01-10	Histamine receptor antagonists

Publications (1)

Publication Number	Publication Date
HUP0302767A2 true HUP0302767A2 (hu)	2003-11-28

Family

ID=9906993

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0302767A HUP0302767A2 (hu)	2001-01-17	2002-01-10	Hisztamin receptor antagonista hatóanyagok

Country Status (32)

Country	Link
EP (1)	EP1353657A1 (pl)
JP (1)	JP2004517883A (pl)
KR (1)	KR20030069216A (pl)
CN (1)	CN1486178A (pl)
AP (1)	AP2002002401A0 (pl)
AR (1)	AR032101A1 (pl)
BG (1)	BG107834A (pl)
BR (1)	BR0206502A (pl)
CA (1)	CA2435121A1 (pl)
CR (1)	CR6983A (pl)
CZ (1)	CZ20031853A3 (pl)
DO (1)	DOP2002000325A (pl)
EA (1)	EA200300537A1 (pl)
EC (1)	ECSP034692A (pl)
EE (1)	EE200300335A (pl)
GB (1)	GB0101223D0 (pl)
GT (1)	GT200200003A (pl)
HU (1)	HUP0302767A2 (pl)
IL (1)	IL156087A0 (pl)
IS (1)	IS6818A (pl)
MA (1)	MA26980A1 (pl)
MX (1)	MXPA03006408A (pl)
NO (1)	NO20033223L (pl)
OA (1)	OA12440A (pl)
PA (1)	PA8537101A1 (pl)
PL (1)	PL362793A1 (pl)
PY (1)	PY0200477A (pl)
SK (1)	SK8572003A3 (pl)
SV (1)	SV2003000849A (pl)
TN (1)	TNSN02003A1 (pl)
WO (1)	WO2002056871A2 (pl)
ZA (1)	ZA200304180B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030133931A1 (en) *	2001-12-21	2003-07-17	Robin Thurmond	Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
EP1545596A4 (en) *	2002-09-06	2005-12-28	Janssen Pharmaceutica Nv	USE OF HISTAMINE H4 RECEPTOR MODULATORS FOR THE TREATMENT OF ALLERGIES AND ASTHMA
WO2004066960A2 (en) *	2003-01-28	2004-08-12	Schering Corporation	Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) *	2008-08-07	2012-08-07	Pulmagen Therapeutics (Inflammation) Limited	Respiratory disease treatment
WO2013151982A1 (en)	2012-04-03	2013-10-10	Arena Pharmaceuticals, Inc.	Methods and compounds useful in treating pruritus, and methods for identifying such compounds
HUE039713T2 (hu)	2012-06-08	2019-02-28	Sensorion	H4 receptor inhibitorok tinnitus kezelésére
CN119823227B (zh) *	2025-01-14	2025-07-04	广州迪卡德营养科技有限公司	一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
2002
- 2002-01-10 IL IL15608702A patent/IL156087A0/xx unknown
- 2002-01-10 CA CA002435121A patent/CA2435121A1/en not_active Abandoned
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/en not_active Ceased
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/sk unknown
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/hu unknown
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/es unknown
- 2002-01-10 CN CNA028036840A patent/CN1486178A/zh active Pending
- 2002-01-10 EA EA200300537A patent/EA200300537A1/ru unknown
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/pt not_active IP Right Cessation
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/ko not_active Ceased
- 2002-01-10 PL PL02362793A patent/PL362793A1/pl not_active Application Discontinuation
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/cs unknown
- 2002-01-10 EE EEP200300335A patent/EE200300335A/xx unknown
- 2002-01-10 EP EP02732099A patent/EP1353657A1/en not_active Withdrawn
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/ja not_active Withdrawn
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/es unknown
- 2002-01-14 PY PY200200200477A patent/PY0200477A/es unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/es unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/es not_active Application Discontinuation
- 2002-01-16 AR ARP020100145A patent/AR032101A1/es not_active Application Discontinuation
- 2002-01-16 GT GT200200003A patent/GT200200003A/es unknown
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/fr unknown
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
2003
- 2003-05-15 IS IS6818A patent/IS6818A/is unknown
- 2003-05-21 BG BG107834A patent/BG107834A/bg unknown
- 2003-05-22 CR CR6983A patent/CR6983A/es not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/fr unknown
- 2003-07-16 NO NO20033223A patent/NO20033223L/no not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/es unknown

Also Published As

Publication number	Publication date
DOP2002000325A (es)	2003-01-31
EP1353657A1 (en)	2003-10-22
GT200200003A (es)	2002-08-19
PY0200477A (es)	2004-06-01
ECSP034692A (es)	2003-08-29
PL362793A1 (pl)	2004-11-02
NO20033223D0 (no)	2003-07-16
JP2004517883A (ja)	2004-06-17
WO2002056871A2 (en)	2002-07-25
IS6818A (is)	2003-05-15
SV2003000849A (es)	2003-01-13
ZA200304180B (en)	2004-06-15
TNSN02003A1 (fr)	2005-12-23
BG107834A (bg)	2004-01-30
AR032101A1 (es)	2003-10-22
CR6983A (es)	2003-11-25
SK8572003A3 (en)	2004-07-07
CN1486178A (zh)	2004-03-31
AP2002002401A0 (en)	2002-03-31
IL156087A0 (en)	2003-12-23
BR0206502A (pt)	2003-10-21
KR20030069216A (ko)	2003-08-25
EE200300335A (et)	2003-12-15
OA12440A (en)	2006-05-22
PA8537101A1 (es)	2002-08-29
EA200300537A1 (ru)	2004-02-26
MA26980A1 (fr)	2004-12-20
MXPA03006408A (es)	2003-10-15
CZ20031853A3 (cs)	2004-07-14
CA2435121A1 (en)	2002-07-25
GB0101223D0 (en)	2001-02-28
NO20033223L (no)	2003-07-16

Publication	Publication Date	Title
CN1784221B (zh)	2010-07-07	影响体重减轻的组合物
US20020052312A1 (en)	2002-05-02	Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
US20080020076A1 (en)	2008-01-24	Methods and Therapies for Potentiating a Therapeutic Action of an Alpha-2 Adrenergic Receptor Agonist and Inhibiting and/or Reversing Tolerance to Alpha-2 Adrenergic Receptor Agonists
WO2004091593A2 (en)	2004-10-28	Methods for the treatment of pain comprising opioid antagonists
JP2008509142A (ja)	2008-03-27	体重減少に影響を及ぼすためのブプロピオンと第２の化合物との組合せ
HUP0302767A2 (hu)	2003-11-28	Hisztamin receptor antagonista hatóanyagok
JP7433331B2 (ja)	2024-02-19	特発性肺線維症を治療するための組成物及び方法
US20020198226A1 (en)	2002-12-26	Analgesic composition and method
KR20060004959A (ko)	2006-01-16	신장 기능 저하를 갖는 개별 대상자의 이뇨 작용 개선 방법
US20110263542A1 (en)	2011-10-27	Methods to treat pain using an alpha-2 adrenergic agonist and an endothelin antagonist
EP4051276B1 (en)	2025-08-06	Use of glutamate 2b receptor antagonists and sigma receptor agonsists as antitussives
AU2008333220B2 (en)	2014-04-24	Mequitazine for treating or preventing pathologies involving histamine H4 receptors
US20020132755A1 (en)	2002-09-19	Histamine receptor antagonists
US20100022574A1 (en)	2010-01-28	Methods to Treat Pain Using an Alpha-2 Adrenergic Agonist and an Endothelin Antagonist
HK1060300A (en)	2004-08-06	Histamine receptor antagonists
AU2002216328A1 (en)	2002-07-30	Histamine receptor antagonists
KR100807480B1 (ko)	2008-02-25	피리베딜의 경비 투여용 약제 조성물
AU2018375087B2 (en)	2023-10-05	Novel analgesic pharmaceutical formulations and uses thereof
US20080188508A1 (en)	2008-08-07	Methods and Therapies for Potentiating a Therapeutic Action of an Opioid Receptor Agonist and Inhibiting and/or Reversing Tolerance to Opioid Receptor Agonists